Improper Disclosures Clause Samples

The Improper Disclosures clause defines and prohibits the unauthorized sharing or release of confidential or sensitive information by a party. Typically, this clause outlines what constitutes an improper disclosure, such as revealing trade secrets, client data, or proprietary business information to third parties without consent. It may also specify the consequences or remedies if such a disclosure occurs. The core function of this clause is to protect the interests of the parties by deterring leaks of valuable information and providing a clear framework for addressing breaches of confidentiality.
POPULAR SAMPLE Copied 1 times
Improper Disclosures. Report all unauthorized or otherwise improper disclosures of PHI, or security incident, to the Covered Entity within two days of the Business Associates knowledge of such event.
View SourceView Similar (7)
Improper Disclosures. In the event that either Party discloses Information other than in accordance with Sections 4.3 and 4.4, the non-breaching Party shall have the right to seek compensation from the breaching Party in addition to and not in place of any other non-monetary remedies available for such breach of Sections 4.3 and 4.4. Entitlement to compensation and the amount of the compensation shall be submitted to dispute resolution in accordance with Section 10.6.
View SourceView Similar (2)
Improper Disclosures. 3.2.1 Business Associate shall track all disclosures of Protected Health Information to third parties, including those made to subcontractors and agents, other than those disclosures that meet the exception criteria of 45 CFR Section 164.528. 3.2.2 In the event of any use or disclosure of PHI that is improper under this Agreement but does not constitute a Breach, Business Associate shall report such use or disclosure to Covered Entity within ten (10) business days after the date on which Business Associate becomes aware of such use or disclosure.
View Source
Improper Disclosures. BA shall report any unauthorized or improper use or disclosure of PHI regarding the terms and conditions of this Agreement or applicable federal and state laws to CE as soon as practicable, but in no event later than five (5) business days of the date on which BA becomes aware of such unauthorized or improper use or disclosure. BA shall, in consultation with CE, mitigate to the extent practicable any harmful effect of such improper disclosures.
View Source
Improper Disclosures. Clarity PSO shall notify Client in a timely manner after discovery of any Disclosure of Client’s Patient Safety Work Product by Clarity PSO that is not permitted by this Agreement. Such improper Disclosure shall be grounds for termination of the Agreement under Section 6.2.
View Source
Improper Disclosures. 5.2.1 Business Associate acknowledges that the HITECH Act requires Business Associate to comply with 45 C.F.R. §§164.308, 164.310, 164.312 and 164.316 as if Business Associate were a Covered Entity, and Business Associate agrees to comply with these provisions of the Security Standards and all additional security provisions of the HITECH Act. 5.2.2 To the extent feasible, Business Associate will use commercially reasonable efforts to secure PHI through technology safeguards that render such PHI unusable, unreadable and indecipherable to individuals unauthorized to acquire or otherwise have access to such PHI in accordance with HHS Guidance published at 74 Federal Register 19006 (April 17, 2009), or such later regulations or guidance promulgated by HHS or issued by the National Institute for Standards and Technology (“NIST’) concerning the protection of identifiable data such as PHI. 5.2.3 Business Associate shall track all disclosures of Protected Health Information to third parties, including those made to Business Associate’s directors, officers, subcontractors, employees, affiliates, agents, and representatives, other than those disclosures that meet the exception criteria of 45 C.F.R. Section 164.528. 5.2.4 Business Associate and Subcontractor shall report to Central Health any Security Incident, unauthorized, or improper use or disclosure of any Protected Health Information under the terms and conditions of this BA Agreement or applicable federal and state laws (including breaches of unsecured protected health information as required by HIPAA) as soon as practicable, but in no event later than two (2) days of the date on which Business Associate (or Business Associate disclosee, as applicable) becomes aware of such use or disclosure.
View Source

Related to Improper Disclosures

  • Disclosure of Confidential Information Any Finance Party may disclose: (a) to any of its Affiliates and Related Funds and any of its or their officers, directors, employees, professional advisers, auditors, partners and Representatives such Confidential Information as that Finance Party shall consider appropriate if any person to whom the Confidential Information is to be given pursuant to this paragraph (a) is informed in writing of its confidential nature and that some or all of such Confidential Information may be price-sensitive information except that there shall be no such requirement to so inform if the recipient is subject to professional obligations to maintain the confidentiality of the information or is otherwise bound by requirements of confidentiality in relation to the Confidential Information; (b) to any person: (i) to (or through) whom it assigns or transfers (or may potentially assign or transfer) all or any of its rights and/or obligations under one or more Finance Documents and to any of that person’s Affiliates, Related Funds, Representatives and professional advisers; (ii) with (or through) whom it enters into (or may potentially enter into), whether directly or indirectly, any sub-participation in relation to, or any other transaction under which payments are to be made or may be made by reference to, one or more Finance Documents and/or one or more Obligors and to any of that person’s Affiliates, Related Funds, Representatives and professional advisers; (iii) appointed by any Finance Party or by a person to whom paragraph (b)(i) or (ii) above applies to receive communications, notices, information or documents delivered pursuant to the Finance Documents on its behalf (including, without limitation, any person appointed under paragraph (c) of Clause 25.14 (Relationship with the Lenders)); (iv) who invests in or otherwise finances (or may potentially invest in or otherwise finance), directly or indirectly, any transaction referred to in paragraph (b)(i) or (b)(ii) above;